Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases.

Radtke T, Crook S, Kaltsakas G, Louvaris Z, Berton D, Urquhart DS, Kampouras A, Rabinovich RA, Verges S, Kontopidis D, Boyd J, Tonia T, Langer D, De Brandt J, Goërtz YMJ, Burtin C, Spruit MA, Braeken DCW, Dacha S, Franssen FME, Laveneziana P, Eber E, Troosters T, Neder JA, Puhan MA, Casaburi R, Vogiatzis I, Hebestreit H.

Eur Respir Rev. 2019 Dec 18;28(154). pii: 180101. doi: 10.1183/16000617.0101-2018. Print 2019 Dec 31. Review.

2.

Neural respiratory drive predicts long-term outcome following admission for exacerbation of COPD: a post hoc analysis.

Patout M, Meira L, D'Cruz R, Lhuillier E, Kaltsakas G, Arbane G, Suh ES, Hart N, Murphy PB.

Thorax. 2019 Sep;74(9):910-913. doi: 10.1136/thoraxjnl-2018-212074. Epub 2019 Apr 26.

PMID:
31028235
3.

Preview of highlighted presentations from the European Respiratory Society' clinical assembly.

Kahn N, Vanfleteren LEGW, Kaltsakas G, Andrianopoulos V, Gompelmann D, de Jong C, Herth FJF.

J Thorac Dis. 2018 Sep;10(Suppl 25):S3034-S3042. doi: 10.21037/jtd.2018.09.17. No abstract available.

4.

Positive airway pressure devices for the management of breathlessness.

D'Cruz RF, Kaltsakas G, Suh ES, Murphy PB, Hart N.

Curr Opin Support Palliat Care. 2018 Sep;12(3):246-252. doi: 10.1097/SPC.0000000000000351. Review.

PMID:
29916844
5.

Neural respiratory drive and cardiac function in patients with obesity hypoventilation syndrome following initiation of non-invasive ventilation.

Onofri A, Patout M, Kaltsakas G, Lhuillier E, Mushemi-Blake S, Arbane G, Pengo MF, Marino P, Steier J.

J Thorac Dis. 2018 Jan;10(Suppl 1):S135-S143. doi: 10.21037/jtd.2017.12.129.

6.

Sleep disordered breathing in motor neurone disease.

D'Cruz RF, Murphy PB, Kaltsakas G.

J Thorac Dis. 2018 Jan;10(Suppl 1):S86-S93. doi: 10.21037/jtd.2017.12.19. Review.

7.

Home-based maintenance tele-rehabilitation reduces the risk for acute exacerbations of COPD, hospitalisations and emergency department visits.

Vasilopoulou M, Papaioannou AI, Kaltsakas G, Louvaris Z, Chynkiamis N, Spetsioti S, Kortianou E, Genimata SA, Palamidas A, Kostikas K, Koulouris NG, Vogiatzis I.

Eur Respir J. 2017 May 25;49(5). pii: 1602129. doi: 10.1183/13993003.02129-2016. Print 2017 May.

8.

Effect of pulmonary rehabilitation on tidal expiratory flow limitation at rest and during exercise in COPD patients.

Theodorakopoulou EP, Gennimata SA, Harikiopoulou M, Kaltsakas G, Palamidas A, Koutsoukou A, Roussos C, Kosmas EN, Bakakos P, Koulouris NG.

Respir Physiol Neurobiol. 2017 Apr;238:47-54. doi: 10.1016/j.resp.2017.01.008. Epub 2017 Jan 18.

PMID:
28109942
9.

Interval training induces clinically meaningful effects in daily activity levels in COPD.

Louvaris Z, Spetsioti S, Kortianou EA, Vasilopoulou M, Nasis I, Kaltsakas G, Koulouris NG, Vogiatzis I.

Eur Respir J. 2016 Aug;48(2):567-70. doi: 10.1183/13993003.00679-2016. Epub 2016 Jun 23. No abstract available.

10.

Hemodynamic effects of high intensity interval training in COPD patients exhibiting exercise-induced dynamic hyperinflation.

Nasis I, Kortianou E, Vasilopoulou Μ, Spetsioti S, Louvaris Z, Kaltsakas G, Davos CH, Zakynthinos S, Koulouris NG, Vogiatzis I.

Respir Physiol Neurobiol. 2015 Oct;217:8-16. doi: 10.1016/j.resp.2015.06.006. Epub 2015 Jun 23.

PMID:
26112284
11.

Impact of hemodialysis on dyspnea and lung function in end stage kidney disease patients.

Palamidas AF, Gennimata SA, Karakontaki F, Kaltsakas G, Papantoniou I, Koutsoukou A, Milic-Emili J, Vlahakos DV, Koulouris NG.

Biomed Res Int. 2014;2014:212751. doi: 10.1155/2014/212751. Epub 2014 May 8.

12.

Prediction of postoperative lung function in patients with lung cancer: the role of quantitative CT imaging.

Papageorgiou CV, Kaltsakas G, Koulouris NG.

Chest. 2014 Apr;145(4):927-8. doi: 10.1378/chest.13-2971. No abstract available.

PMID:
24687722
13.

Activity monitoring reflects cardiovascular and metabolic variations in COPD patients across GOLD stages II to IV.

Kortianou EA, Louvaris Z, Vasilopoulou M, Nasis I, Kaltsakas G, Koulouris NG, Vogiatzis I.

Respir Physiol Neurobiol. 2013 Dec 1;189(3):513-20. doi: 10.1016/j.resp.2013.08.014. Epub 2013 Sep 3.

PMID:
24013005
14.

Dyspnea and respiratory muscle strength in end-stage liver disease.

Kaltsakas G, Antoniou E, Palamidas AF, Gennimata SA, Paraskeva P, Smyrnis A, Koutsoukou A, Milic-Emili J, Koulouris NG.

World J Hepatol. 2013 Feb 27;5(2):56-63. doi: 10.4254/wjh.v5.i2.56.

15.

Methods for Assessing Expiratory Flow Limitation during Tidal Breathing in COPD Patients.

Koulouris NG, Kaltsakas G, Palamidas AF, Gennimata SA.

Pulm Med. 2012;2012:234145. Epub 2012 Sep 2.

16.

On- and off-exercise kinetics of cardiac output in response to cycling and walking in COPD patients with GOLD Stages I-IV.

Vasilopoulou MK, Vogiatzis I, Nasis I, Spetsioti S, Cherouveim E, Koskolou M, Kortianou EA, Louvaris Z, Kaltsakas G, Koutsoukou A, Koulouris NG, Alchanatis M.

Respir Physiol Neurobiol. 2012 May 31;181(3):351-8. doi: 10.1016/j.resp.2012.03.014. Epub 2012 Mar 29.

PMID:
22484002
17.

The expression of human leukocyte antigens class I and II in women with endometriosis or adenomyosis.

Baka S, Frangou-Plemenou M, Panagiotopoulou E, Makrakis E, Kaltsakas G, Hassiakos D, Kondi-Pafiti A.

Gynecol Endocrinol. 2011 Jun;27(6):419-24. doi: 10.3109/09513590.2010.495429. Epub 2010 Jun 23.

PMID:
20569098
18.

Role of quantitative CT in predicting postoperative FEV1 and chronic dyspnea in patients undergoing lung resection.

Papageorgiou CV, Antoniou D, Kaltsakas G, Koulouris NG.

Multidiscip Respir Med. 2010 Jun 30;5(3):188-93. doi: 10.1186/2049-6958-5-3-188.

Supplemental Content

Loading ...
Support Center